Regular Strength Pain Relief Capsule, Liquid Filled
NDC Package 27854-388-01
Package Information
Regular Strength Pain Relief (acetaminophen) capsules is do not take more than directed (seeĀ Overdose warning)adults and children 12 years and overtake 2 softgels every 4 to 6 hours while symptoms lastdo not take more than 10 softgels in 24 hoursdo not use for more than 10 days unless directed by a doctorchildren 6 years to under 12 yearstake 1 softgel every 4 to 6 hours while symptoms lastdo not take more than 5 softgels in 24 hoursdo not use for more than 5 days unless directed by a doctorchildren under 6 yearsask a doctor. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Belmora Llc, this product is identified by NDC 27854-388 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 198436 - acetaminophen 325 MG Oral Capsule
- RxCUI: 198436 - APAP 325 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 27854 - Belmora Llc
- 27854-388 - Regular Strength Pain Relief
- 27854-388-01 - 1 BOTTLE in 1 CARTON / 20 CAPSULE, LIQUID FILLED in 1 BOTTLE
- 27854-388 - Regular Strength Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 27854-388-01 identifies a specific commercial package of 1 bottle in 1 carton / 20 capsule, liquid filled in 1 bottle of Regular Strength Pain Relief, a human over the counter drug labeled by Belmora Llc. This capsule, liquid filled is formulated for oral use and contains acetaminophen as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belmora Llc on January 05, 2022. The current certification is valid through December 31, 2027.
How is this Belmora Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 27854038801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.